GLG Partners’s Eli Lilly LLY Stock Holding History

GLG Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$74K	Buy	+880	New	+$74.9K	﹤0.01%	429
2015 Q3	–	Sell	-16,223	Closed	-$1.35M	–	506
2015 Q2	$1.35M	Hold	16,223	–	–	0.04%	328
2015 Q1	$1.18M	Sell	16,223 -4	-0%	-$285	0.04%	290
2014 Q4	$1.12M	Buy	+16,227	New	+$1.1M	0.03%	294
2014 Q2	–	Sell	-1,965	Closed	-$116K	–	404
2014 Q1	$116K	Buy	+1,965	New	+$110K	﹤0.01%	343
2013 Q3	–	Sell	-5,317	Closed	-$261K	–	221
2013 Q2	$261K	Buy	+5,317	New	+$289K	0.01%	265

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GLG Partners's LLY Position: Q4 2017 in Review

GLG Partners opened a new position in Eli Lilly (LLY) in Q4 2017: 880 shares worth $74K. The stake represents ﹤0.01% of the portfolio and ranks #429 among its holdings. This is a return to the name: GLG Partners previously reported a position in LLY as recently as Q2 2015.

GLG Partners first reported a position in LLY in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.35M in Q2 2015. 1,373 funds tracked by Wall St. Rank hold LLY as of Q4 2017.

GLG Partners held 880 shares of Eli Lilly worth $74K as of Q4 2017.
Eli Lilly was a new GLG Partners position in Q4 2017.
Eli Lilly made up ﹤0.01% of GLG Partners's portfolio in Q4 2017, its #429 holding.
GLG Partners first reported a position in Eli Lilly in Q2 2013 and has held it in 6 quarters since.
GLG Partners's Eli Lilly position peaked at $1.35M in Q2 2015.
1,373 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.